INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2015

Adjunctive crocin improved depression, anxiety, and general health scores in depressed patients.

A four-week randomized, double-blind, placebo-controlled trial tested crocin tablets (30 mg/day) alongside SSRI therapy in 40 patients with major depressive disorder. The crocin group demonstrated significantly greater decreases in Beck Depression Inventory (17.6 vs. 6.15), Beck Anxiety Inventory (12.7 vs. 2.6), and General Health Questionnaire scores (17.2 vs. 10.3) compared to placebo (p < 0.0001). Limitations included a brief intervention period, modest sample size, and dependence on self-reported evaluations.

Study type
Randomized double-blind placebo-controlled trial
Who was studied
40 adults aged 24-50 with major depressive disorder, Iran
What was measured
Depression, anxiety, and general health scores

THE PAPER

Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.

Talaei A, Hassanpour Moghadam M, Sajadi Tabassi SA, Mohajeri SA. J Affect Disord, 2015.

PubMed 25484177 ↗DOI 10.1016/j.jad.2014.11.035 ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.